C. Wicker

Administration of gamma‐hydroxybutyrate instead of beta‐hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: A case report on a medication prescribing error

P. de Lonlay, A. Brassier, S. Renolleau, 2020, JIMD reports.

Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up

P. de Lonlay, A. Brassier, J. Arnoux, 2021, Orphanet Journal of Rare Diseases.

Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency

P. de Lonlay, J. Maizel, J. Bouchereau, 2019, Case reports in critical care.

5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy

M. Ducreux, P. de Lonlay, A. Hollebecque, 2019, Anti-cancer drugs.

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort

A. Servais, P. de Lonlay, B. Pigneur, 2020, Molecular genetics and metabolism reports.

Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: A retrospective analysis in a large French cohort

A. Servais, G. Touati, A. Brassier, 2021, Molecular genetics and metabolism reports.

Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management.

N. Boddaert, A. Kaminska, A. Harroche, 2023, Molecular genetics and metabolism.

French recommendations for the management of glycogen storage disease type III

P. Laforêt, R. Froissart, V. Decostre, 2023, European Journal of Medical Research.